Navigation Links
Carma Laboratories Launches New Carmex(R) Web Site; Unveils Top 10 Reasons for a Virtual Visit
Date:11/19/2008

MILWAUKEE, Nov. 19 /PRNewswire/ -- Carma Laboratories, Inc., the makers of Carmex(R) lip balms, today unveiled its new Web site: http://www.mycarmex.com. In association with the new site's launch, the company also announced the top 10 reasons to visit mycarmex.com.

"We know that Carmex users are serious about their lip balm and they also have a passion for enjoying life," said Paul Woelbing, president of Carma Laboratories. "The new Web site reflects this lifestyle and enables our customers to insert Carmex fun into more than just their pocket or purse," he added.

Woelbing went on to say, "For years we have had to ward off rumors that our lip balm is addictive, even though all Carmex products are in full compliance with the Food and Drug Administration. However, I cannot make that claim about mycarmex.com -- the new Web site may be habit forming," he added.

In addition to fun, interactive activities that allow visitors to create their own electronic greetings or design their own branded apparel, mycarmex.com features more traditional offerings, such as product descriptions, company history and answers to commonly (and not so commonly) asked questions.

Carmex lip balm is available in a variety of forms like jar, tube and stick; a variety of flavors like cherry, strawberry and mint; and many with sun protection.

                     Top 10 Reasons to Visit mycarmex.com

    10) Launch your movie career (direct link to YouTube to upload Carmex
        videos).
     9) Find out what supermodels and the TSA have in common.
     8) Get free stuff (50 lucky winners chosen each week)!
     7) Plan a Carmex fashion show, complete with branded shirts, shoes and
        skateboards.
     6) Get into the holiday spirit (a portion of proceeds from merchandise
        sales will support Toys for Tots).
     5) Discover double-secre
'/>"/>
SOURCE Carma Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
5. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
6. Andrew Lessmans TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System
7. Mesa Laboratories Names New Vice President of Sales and Marketing
8. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
9. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
10. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
11. JDRF partners with Housey Pharmaceutical Research Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...ht problems faced by youngsters with the disease ,...Children with type 1 diabetes are more likely to b...asing their risk of serious health complications, ...study that explored the weight problems faced by U... form of the disease that usually shows up in chil...
(Date:7/2/2009)... in the DNA of the hepatitis B virus (HBV) are ass...ay help predict which patients with HBV infections...o a large meta-analysis in the Journal of the Nat..., HBV infection is a known cause of hepatocellul...cancer. Previous studies have looked at whether pa...
(Date:7/2/2009)...2 Tuesday night saw the launch of ...Barcelona where U2 kicked off their new tour to a ...RED)ZONES are prime location areas directly adjace...he U2 tour. The tickets for the (RED)ZONES are av... the ticket sales going to the Global Fund to help...
(Date:7/2/2009)...atients who receive brachytherapy and remain free ...to have a recurrence at 10 years, according to a s...rnal of Radiation Oncology*Biology*Physics , the o...ion Oncology (ASTRO)., Brachytherapy is the place...umor either permanently or temporarily, depending ...
Breaking Medicine News(10 mins):Health News:Kids With Type 1 Diabetes Often Overweight 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 2Health News:(RED)ZONES Launch at First U2 360 Degrees Concert in Barcelona 3
...by a team of researchers have revealed the connect...eromas formation in patients //at a higher risk fo...nk may be due to blockages containing calcium in t...o the brain by carotid artery. These blockages, o...
...a, in eastern Nigeria, has reported the deadly H5N...oint out that in most //of the other parts of Afri...e first African country to be hit by bird flu, has...h experts warn that due to ineffective surveillanc...
...turned to begging in order to pay his wife's medic...fe Mehrunisa was admitted to the Tata Memorial Hos...ia reports said. After treatment, she was declared...ere shocked to receive a whopping Rs.22,000 bill -...
...ion doctors at the All India Institute of Medical ...'s intervention to ensure strict implementation of...ved category students and doctors at the institute...ean of the institute, Medicos Forum for Equal Oppo...
Other Medicine News:
(Date:7/1/2009)...KJAVIK, Iceland, July 1 ...a ever undertaken has revealed several new common,...an genome (SNPs) linked to,risk of the disease. T...sts,led by a team from deCODE genetics (Nasdaq: ...patients and control participants from fourteen co...
(Date:6/30/2009)...GO, June 30 Accumetrics, Inc. anno...patients) in the enrollment of its landmark clinic...h A V erifyNow(R) Assay I mpact on T hrombosis ...ed to demonstrate the value of providing clinician... poor responders to clopidogrel (Plavix(R)). The ...
(Date:6/29/2009)...tive Study Seeks to Assess RSV Burden in Outpatien...ommitment to Pediatric Research , , GAITHERSB...ues to advance its commitment to pediatric researc...onal prospective study designed to assess the burd...erm infants 32-to-35 weeks gestational age (GA) in...
(Date:6/29/2009)...THAMPTON, England, June 29 Vantia ...developing novel, small molecule drugs,targeting ...tive results from,a Phase IIa clinical trial of i...a. The trial showed that oral VA106483 was success...-diuretic effect in patients, as determined by,in...
Breaking Medicine Technology:deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3AutoImmune Inc Reports 2008 Fourth Quarter and Year End Financial Results 11016 1AutoImmune Inc Reports 2008 Fourth Quarter and Year End Financial Results 11016 2AutoImmune Inc Reports 2008 Fourth Quarter and Year End Financial Results 11016 3AutoImmune Inc Reports 2008 Fourth Quarter and Year End Financial Results 11016 4Breast Cancer Awareness Event Including Free Educational Seminars 39635 1Breast Cancer Awareness Event Including Free Educational Seminars 39635 2Cardiac imaging highlighted at Biennial ICNC 9 39632 1Cardiac imaging highlighted at Biennial ICNC 9 39632 2Cardiac imaging highlighted at Biennial ICNC 9 39632 3Cardiac imaging highlighted at Biennial ICNC 9 39632 4Alzheimers Disease Neuroimaging Initiative announces completion of genome wide analysis 39629 1Alzheimers Disease Neuroimaging Initiative announces completion of genome wide analysis 39629 2Alzheimers Disease Neuroimaging Initiative announces completion of genome wide analysis 39629 3
...iotech (ACTI.ST), today,announced new positive cli...e treatment of prostate cancer. , By step-wise dos...achieved, which corresponds to a doubling of the p...vel of 0.5 mg/day. This,means that a step-wise int...day to be administered in future clinical trials. ...
...ewswire-FirstCall/ --,Schering-Plough Corporation ... of its novel oral thrombin receptor antagonist (T...l Scientific Sessions,of the of Cardiology (ACC.07...-27 in New Orleans. The Phase II trial, referred t...ous Coronary,Intervention (TRA-PCI) trial, has bee...
Other Medicine Technology:Positive Clinical Data for TASQ - Active Biotech's Novel Treatment,of Prostate Cancer 2Schering-Plough Announces Presentation of Phase II Trial Results,for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual,Meeting of The American College of Cardiology/i2 Summit 2
...-based sealing option for thermal cycling in thin-...sures secure sample storage or transport before or...ycling when supplemental pressure is applied by a ... when using this sealer on semi-skirted microplate...
TD silicone foam compression pad. Use with plates sealed with TDX or OptiTape.
Inquire
The Heat Sealing Foil and Heat
Medicine Products: